Antibiotic resistance determinants in Acinetobacter spp and clinical outcomes in patients from a major military treatment facility

American Journal of Infection Control

Volumn 38, Issue 1, 2010, Pages 63-65

  Perez, Federico ^a,b   Hujer, Andrea M ^b   Hulten, Edward A ^c   Fishbain, Joel ^c   Hujer, Kristine M ^b   Aron, David ^b   Thweatt, Katherine ^b   Donskey, Curtis J ^b   Bonomo, Robert A ^b,d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CROSS-SECTIONAL STUDY; GENOTYPE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MILITARY SERVICE; OUTCOME ASSESSMENT; PHENOTYPE;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HOSPITALS, MILITARY; HUMANS; LENGTH OF STAY; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 74449092524     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.05.007     Document Type: Article

References (9)

1. Munoz-Price L.S., and Weinstein R.A. Acinetobacter infection. N Engl J Med 358 (2008) 1271-1281
2. Maragakis L.L., and Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46 (2008) 1254-1263
3. Lee N.Y., Lee H.C., Ko N.Y., Chang C.M., Shih H.I., Wu C.J., et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 28 (2007) 713-719
4. Sunenshine R.H., Wright M.O., Maragakis L.L., Harris A.D., Song X., Hebden J., et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13 (2007) 97-103
5. Kwon K.T., Oh W.S., Song J.H., Chang H.H., Jung S.I., Kim S.W., et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteremia. J Antimicrob Chemother 59 (2007) 525-530
6. Peleg A.Y., Seifert H., and Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21 (2008) 538-582
7. Scott P., Deye G., Srinivasan A., Murray C., Moran K., Hulten E., et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 44 (2007) 1577-1584
8. Hujer K.M., Hujer A.M., Hulten E.A., Bajaksouzian S., Adams J.M., Donskey C.J., et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50 (2006) 4114-4123
9. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., and Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51 (2007) 3471-3484